NEMESIS BIOSCIENCE

nemesis-bioscience-logo

Nemesis Bioscience is a UK-based biopharmaceutical company developing products to resurrect anti-microbial therapies made ineffective by increasing microbial resistance. The company develops Nemesis Symbiotics that will make existing antibiotics work again, prevent the spread of resistance genes, and so also protect the efficacy of new antibiotics. The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria. Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors, and in vivo synthesis of biofuels and therapeutics. The company was awarded the Kingโ€™s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions.

#SimilarOrganizations #People #Financial #Website #More

NEMESIS BIOSCIENCE

Industry:
Biopharma Biotechnology Medical Pharmaceutical

Founded:
2014-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.nemesisbio.com

Total Employee:
1+

Status:
Active

Contact:
+4401223804075

Email Addresses:
[email protected]

Total Funding:
1000 K GBP

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

jenrin-discovery-logo

Jenrin Discovery

Jenrin Discovery is a biopharmaceutical Company.

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.

Current Employees Featured

alastair-riddell_image

Alastair Riddell
Alastair Riddell Chairman @ Nemesis Bioscience
Chairman

gi-mikawa_image

Gi Mikawa
Gi Mikawa CMO @ Nemesis Bioscience
CMO

frank-massam_image

Frank Massam
Frank Massam Founder & CEO @ Nemesis Bioscience
Founder & CEO

mark-mccamish_image

Mark McCamish
Mark McCamish Preclinical Advisor @ Nemesis Bioscience
Preclinical Advisor

conrad-lichtenstein_image

Conrad Lichtenstein
Conrad Lichtenstein Founder & CSO @ Nemesis Bioscience
Founder & CSO

Founder


conrad-lichtenstein_image

Conrad Lichtenstein

frank-massam_image

Frank Massam

Investors List

future-planet-capital_image

Future Planet Capital

Future Planet Capital investment in Seed Round - Nemesis Bioscience

mark-mccamish_image

Mark McCamish

Mark McCamish investment in Seed Round - Nemesis Bioscience

development-bank-of-wales_image

Development Bank of Wales

Development Bank of Wales investment in Seed Round - Nemesis Bioscience

rainbow-seed-fund_image

UK Innovation & Science Seed Fund

UK Innovation & Science Seed Fund investment in Seed Round - Nemesis Bioscience

development-bank-of-wales_image

Development Bank of Wales

Development Bank of Wales investment in Seed Round - Nemesis Bioscience

Official Site Inspections

http://www.nemesisbio.com

  • Host name: mail.domain-holding.co.uk
  • IP address: 213.171.195.105
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Nemesis Bioscience" on Search Engine